Dynamic modulation of phosphoprotein expression in ovarian cancer xenograft models-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dynamic modulation of phosphoprotein expression in ovarian cancer xenograft models

Published:2016-03-10 Issue:1 Volume:16 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Koussounadis Antonis,Langdon Simon P.,Um Inhwa,Kay Charlene,Francis Kyle E.,Harrison David J.,Smith V. Anne

Funder

Medical Research Scotland (GB)

FP7-Directorate-General for Research and Innovation of the European Commission

Chief Scientist Office of Scotland

Scottish Funding Council (GB)

University Of Edinburgh (GB)

Wikwemikong Board of Education

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s12885-016-2212-6

Reference53 articles.

1. Covens A, Carey M, Bryson P, Verma S, Fung Kee Fung M, et al. Systematic review of first-line chemotherapy for newly diagnosed postoperative patients with stage II, III, or IV epithelial ovarian cancer. Gynecol Oncol. 2002;85:71–80.

2. Moss C, Kaye SB. Ovarian cancer: progress and continuing controversies in management. Eur J Cancer. 2002;38:1701–7.

3. Levi F, Lucchini F, Negri E, Boyle P, La Vecchia C. Cancer mortality in Europe, 1995–1999, and an overview of trends since 1960. Int J Cancer. 2004;110:155–69.

4. Vogelstein B, Kinzler K. Cancer genes and the pathways they control. Nat Med. 2004;10:789–99.

5. Kan Z, Jaiswal BS, Stinson J, Janakiraman V, Bhatt D, Stern HM, et al. Diverse somatic mutation patterns and pathway alterations in human cancers. Nature. 2010;466:869–73.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. LYN kinase and estrogen receptor ERα: involvement in carcinogenesis and potential therapeutic target for tumors;Advances in Molecular Oncology;2021-11-05

2. Evaluation of the dual mTOR/PI3K inhibitors Gedatolisib (PF-05212384) and PF-04691502 against ovarian cancer xenograft models;Scientific Reports;2019-12

3. Molecular Response to Neoadjuvant Chemotherapy in High-Grade Serous Ovarian Carcinoma;Molecular Cancer Research;2018-03-09

4. Evaluation of the combination of the dual m-TORC1/2 inhibitor vistusertib (AZD2014) and paclitaxel in ovarian cancer models;Oncotarget;2017-12-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3